SCHEMBL1668962

SCHEMBL1668962

NC(=O)c1c(O)cccc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 6/20 0.59
CA1 P00915 5/20 0.59
CA12 O43570 5/20 0.59
CA14 Q9ULX7 5/20 0.59
CA7 P43166 4/20 0.59
CA9 Q16790 4/20 0.59
THRB P10828 1/20 0.56
HSD17B10 Q99714 4/20 0.54
ALDH1A1 P00352 4/20 0.54
MAPT P10636 4/20 0.54
HPGD P15428 3/20 0.54
KDM4E B2RXH2 3/20 0.54
TSHR P16473 2/20 0.54
PIM1 P11309 1/20 0.45
PARP1 P09874 2/20 0.44
RECQL P46063 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
EGFR P00533 2/20 0.43
LMNA P02545 2/20 0.43
FYN P06241 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7332948 0.85 CA1 (0.50) CA2CA1CA12CA14CA7
SCHEMBL2890578 0.85 CA12 (0.50) CA2CA1CA12CA14CA7
SCHEMBL698805 0.85 KDM4E (0.64) CA2CA1CA12CA14CA7
SCHEMBL3713424 0.84 THRB (0.52) CA2CA1CA12CA14CA7
SCHEMBL30788037 0.84 THRB (0.52) CA2CA1CA12CA14CA7
SCHEMBL17329160 0.84 ALDH1A1 (0.52) CA2CA1CA12CA14CA7
SCHEMBL22904424 0.84 CA1 (0.48) CA2CA1CA12CA14CA7
SCHEMBL8174459 0.84 CES2 (0.54) CA2CA1CA12CA14CA7
SCHEMBL2000711 0.82 HSD17B10 (0.46) CA2CA1CA12CA14CA7
SCHEMBL2343686 0.82 G6PD (0.59) CA2CA1CA12CA14CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3937280-A1 METHOD FOR PREPARING A POROUS CARBONATED AND NITROGENATED MATERIAL WITH METAL DOPANT USEFUL, IN PARTICULAR, AS A CATALYST FOR OXYGEN REDUCTION (ORR) Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2022-01-12 EP claimed
EP-3780197-A1 METHOD FOR PREPARING A POROUS CARBONACEOUS AND NITROGENOUS MATERIAL WITH METALLIC DOPANT, IN PARTICULAR USEFUL AS A CATALYST FOR OXYGEN REDUCTION REACTION (ORR) Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2021-02-17 EP claimed
US-20200205541-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2020-07-02 US claimed
CN-102398900-B Single-layer graphene of a kind of energy stable dispersion and preparation method thereof TORAY FIBERS & TEXTILES RESEARCH LABORATORIES (CHINA) CO.,LTD. (CN) 2015-09-30 CN claimed
US-20130298933-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL (FR) 2013-11-14 US claimed
EP-2485678-A1 COFERONS AND METHODS OF MAKING AND USING THEM Cornell University (US) 2012-08-15 EP claimed
WO-2011043817-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2011-04-14 WO claimed
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND L'OREAL S.A. (FR) 2010-12-02 US claimed
JP-8291044-A None JP disclosed
CN-121797737-A Iron-titanium shed waste chemical extraction recovery material and preparation method thereof 江苏永超磁性材料有限公司 2026-04-07 CN disclosed
EP-4554549-A1 COMPOSITION COMPRISING SKIN CARE ACTIVE INGREDIENT OR CELLULOSE COMPOUND L'OREAL (FR) 2025-05-21 EP disclosed
CN-119677492-A Composition comprising a skin care active or a cellulose compound 莱雅公司 2025-03-21 CN disclosed
US-20250064703-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL OREAL (FR) 2025-02-27 US disclosed
EP-4452205-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL L'OREAL (FR) 2024-10-30 EP disclosed
US-4460580-A N-Alkylated aminoalcohols and their pharmaceutical compositions useful for the treatment of cardiac insufficiency CIBA-GEIGY CORPORATION (US) 1984-07-17 US disclosed
US-4448730-A ANTITUMOR AGENTS RIET BARTHOLOMEUS VAN T 1984-05-15 US disclosed
US-4394389-A ANTITUMOR AGENTS RIET BARTHOLOMEUS VAN T 1983-07-19 US disclosed
EP-0005848-B1 N-ALKYLATED AMINOALCOHOLS AND THEIR SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM CIBA-GEIGY AG (CH) 1981-12-30 EP disclosed
EP-0015505-A1 3-Amino-1,2-propane diols, process for their preparation, pharmaceutical compositions containing them and use thereof CIBA-GEIGY AG (CH) 1980-09-17 EP disclosed
EP-0005848-A1 N-Alkylated aminoalcohols and their salts, process for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1979-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200205541-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B CA2 2393/4885CA1 2454/4885CA12 1543/4885
US-20250064703-A1 COMPOSITION COMPRISING SOLUBILIZED POLYPHENOL PROC, GANC, LGALS1 CA2 754/4885CA1 1527/4885CA12 777/4885
US-20100300472-A1 METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND KRT18, TUBB4A, TUBB4B CA2 2393/4885CA1 2454/4885CA12 1543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.